Coronary Artery Disease
4 competing products in clinical development for Coronary Artery Disease.
Pipeline by Phase
Pre-clinical2
Phase 31
Approved1
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Evolocumab | HeartFlow | Approved | Withdrawn | 80 |
| Exenatide | Eli Lilly | Phase 3 | Completed | 77 |
| Rosuvastatin 40mg + Placebo | HeartFlow | Pre-clinical | Recruiting | 18 |
| High intensity lipid lowering | HeartFlow | Pre-clinical | Completed | 18 |